This IFN-high, mitochondrial-DNA–rich microenvironment is unique to SLE and is not observed in RA or psoriasis to the same extent, making ZBP1-dependent PANoptosis a particularly SLE-specific susceptibility factor. This evidence concerns the gene IFNA1 and rheumatoid arthritis.